Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $35.18M.
ENTERPRISE VALUE (EV)
$35.18M
Inovio Pharmaceuticals, Inc.
Market Cap
$79.46M
Enterprise Value (EV)
$35.18M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Inovio Pharmaceuticals, Inc. (INO) | $79.46M | $35.18M |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.31M | $76.67M |
| Sera Prognostics, Inc. (SERA)vs › | $80.96M | $79.57M |
| Pulmonx Corporation (LUNG)vs › | $77.93M | $78.30M |
| Nutriband Inc. (NTRB)vs › | $81.81M | $78.58M |
| MediciNova, Inc. (MNOV)vs › | $82.45M | $57.15M |
| LENSAR Inc (LNSR)vs › | $82.78M | $71.59M |
| Outset Medical, Inc. (OM)vs › | $76.10M | $145.54M |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.82M | $43.52M |
| Cardiff Oncology, Inc. (CRDF)vs › | $83.24M | $74.50M |
Market Cap
$79.46M
Total Debt
$0.00
Cash
$44.27M
Enterprise Value
$35.18M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
